A. Functional magnetic resonance imaging (fMRI)
Mapping the functional consequences of neurodegeneration
Assessing the effect of therapeutic interventions
Monitoring disease progression
B. Magnetic resonance spectroscopy (MRS)
Noninvasive characterization of regional abnormalities in tissue metabolism
Discrimination between PD and atypical parkinsonian syndromes
C. Diffusion-weighted magnetic resonance imaging (dMRI)
Probing for microstructural changes in the cerebral tissue (ADC-maps)
Mapping abnormalities in the organization of white matter tracts (DT-imaging)
PD, Parkinson's disease; ADC, apparent diffusion coefficient; DT, diffusion tensor.
Was this article helpful?